Madrigal Pharmaceuticals, Inc. (MDGL)
NASDAQ: MDGL · Real-Time Price · USD
480.77
+6.49 (1.37%)
Jun 12, 2026, 4:00 PM EDT - Market closed
Madrigal Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 14 analysts polled by S&P Global, Madrigal Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of $678.71. The average 1-year stock price forecast is 41.17% higher than the current stock price, while the lowest is $542 (+12.74%) and the highest is $964 (+100.51%).
Price Target: $678.71 (+41.17%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Madrigal Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 12 | 11 | 11 | 11 | 10 | 10 |
| Buy | 3 | 3 | 3 | 3 | 1 | 1 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 17 | 16 | 16 | 16 | 13 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bank of America Securities | Bank of America Securities | Hold Reiterates $550 → $542 | Hold | Reiterates | $550 → $542 | +12.74% | Jun 11, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $620 | Buy | Reiterates | $620 | +28.96% | May 28, 2026 |
| Truist Financial | Truist Financial | Buy Reiterates $709 → $514 | Buy | Reiterates | $709 → $514 | +6.83% | May 26, 2026 |
| Barclays | Barclays | Buy Reiterates $964 | Buy | Reiterates | $964 | +100.51% | May 8, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $587 → $578 | Buy | Maintains | $587 → $578 | +20.22% | May 7, 2026 |
Financial Forecast
Revenue This Year
1.50B
from 958.40M
Increased by 56.04%
Revenue Next Year
2.21B
from 1.50B
Increased by 47.52%
EPS This Year
-6.52
from -12.73
EPS Next Year
12.38
from -6.52
EPS and Forward PE are based on non-GAAP adjusted numbers.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.6B | ||
| Avg | 1.5B | ||
| Low | 1.4B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 62.2% | ||
| Avg | 56.0% | ||
| Low | 46.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -6.15 | ||
| Avg | -6.52 | ||
| Low | -7.11 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | - | ||
| Low | - |